Terms: = Liver cancer AND FANCA, MGC75158, 2175, ENSG00000187741, FA-H, FA, FAA, FANCH, FA1, FACA AND Treatment
194 results:
1. Sorafenib and tetrakis (4-carboxyphenyl) porphyrin assembled nanoparticles for synergistic targeted chemotherapy and sonodynamic therapy of hepatocellular carcinoma.
Chen Y; Tan Q; Tang Y; Pang E; Peng R; Lan M; Bai D
Biomater Sci; 2024 Mar; 12(7):1864-1870. PubMed ID: 38411494
[TBL] [Abstract] [Full Text] [Related]
2. Research progress, challenges and perspectives of phospholipids metabolism in the LXR‑LPCAT3 signaling pathway and its relation to NAFLD (Review).
Wang J; Li J; Fu Y; Zhu Y; Lin L; Li Y
Int J Mol Med; 2024 Apr; 53(4):. PubMed ID: 38362962
[TBL] [Abstract] [Full Text] [Related]
3. Synthesis and Characterization of Graphene Oxide/Polyethylene Glycol/Folic Acid/Brucine Nanocomposites and Their Anticancer Activity on HepG2 Cells.
Ibrahim IAA; Alzahrani AR; Alanazi IM; Shahzad N; Shahid I; Falemban AH; Nur Azlina MF; Arulselvan P
Int J Nanomedicine; 2024; 19():1109-1124. PubMed ID: 38344441
[TBL] [Abstract] [Full Text] [Related]
4. Enhancing Targeted Therapy in Hepatocellular Carcinoma through a pH-Responsive Delivery System: Folic Acid-Modified Polydopamine-Paclitaxel-Loaded Poly(3-hydroxybutyrate-
Wu M; Wang Q; Peng Y; Liang X; Lv X; Wang S; Zhong C
Mol Pharm; 2024 Feb; 21(2):581-595. PubMed ID: 38131328
[TBL] [Abstract] [Full Text] [Related]
5. Rational design of NIR-II molecule-engineered nanoplatform for preoperative downstaging and imaging-guided surgery of orthotopic hepatic tumor.
Pan Q; Li K; Kang X; Li K; Cheng Z; Wang Y; Xu Y; Li L; Li N; Wu G; Yang S; Qi S; Chen G; Tan X; Zhan Y; Tang L; Zhan W; Yang Q
J Nanobiotechnology; 2023 Dec; 21(1):489. PubMed ID: 38111035
[TBL] [Abstract] [Full Text] [Related]
6. Caffeine-folic acid-loaded-chitosan nanoparticles combined with methotrexate as a novel HepG2 immunotherapy targeting adenosine A2A receptor downstream cascade.
Hamed A; Ghareeb D; Mohamed TM; Hamed M; Nofal MS; Gaber M
BMC Complement Med Ther; 2023 Oct; 23(1):384. PubMed ID: 37891562
[TBL] [Abstract] [Full Text] [Related]
7. pH-Responsive and Actively Targeted Metal-Organic Framework Structures for Multimodal Antitumor Therapy and Inhibition of Tumor Invasion and Metastasis.
Jia W; Jin B; Xu W; Liu S; Mao X; Peng H; Zhang Y
ACS Appl Mater Interfaces; 2023 Nov; 15(43):50069-50082. PubMed ID: 37871135
[TBL] [Abstract] [Full Text] [Related]
8. Autophagy-amplifying nanoparticles evoke immunogenic cell death combined with anti-PD-1/PD-L1 for residual tumors immunotherapy after RFA.
Zhang S; Huang Y; Pi S; Chen H; Ye F; Wu C; Li L; Ye Q; Lin Y; Su Z
J Nanobiotechnology; 2023 Oct; 21(1):360. PubMed ID: 37789342
[TBL] [Abstract] [Full Text] [Related]
9. Hepatic adenoma in a 7-year-old girl: a case report and literature review.
Gao Y; Zhou J; Xie YC; Qiu LJ; Duan L; A ZX; Wu HF; Lv MX
BMC Pediatr; 2023 Aug; 23(1):420. PubMed ID: 37620840
[TBL] [Abstract] [Full Text] [Related]
10. Functionalized ZnMnFe
Liu J; Shi X; Qu Y; Wang G
Nanoscale; 2023 Jul; 15(26):11013-11025. PubMed ID: 37341143
[TBL] [Abstract] [Full Text] [Related]
11. Poly lactic-co-glycolic acid-alginate nanocarrier for efficient drug delivery to liver cancer cells.
Hoseinzadeh M; Mokhtari MJ; Kafilzadeh F; Mohammadnejad J; Taheri Y
IET Nanobiotechnol; 2023 Jul; 17(5):450-464. PubMed ID: 37309704
[TBL] [Abstract] [Full Text] [Related]
12. Magnetic-Manipulated NK Cell Proliferation and Activation Enhance Immunotherapy of Orthotopic liver cancer.
Jiang H; Fu H; Min T; Hu P; Shi J
J Am Chem Soc; 2023 Jun; 145(24):13147-13160. PubMed ID: 37262421
[TBL] [Abstract] [Full Text] [Related]
13. Hepatocyte Nuclear Factor 4α (HNF4α) Plays a Controlling Role in Expression of the Retinoic Acid Receptor β (
Zolfaghari R; Bonzo JA; Gonzalez FJ; Ross AC
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239961
[TBL] [Abstract] [Full Text] [Related]
14. Resveratrol Loaded by Folate-Modified Liposomes Inhibits Osteosarcoma Growth and Lung Metastasis via Regulating JAK2/STAT3 Pathway.
Zhu WT; Zeng XF; Yang H; Jia ML; Zhang W; Liu W; Liu SY
Int J Nanomedicine; 2023; 18():2677-2691. PubMed ID: 37228445
[TBL] [Abstract] [Full Text] [Related]
15. ncRNA-mediated fatty acid metabolism reprogramming in HCC.
Xu K; Xia P; Chen X; Ma W; Yuan Y
Trends Endocrinol Metab; 2023 May; 34(5):278-291. PubMed ID: 36890041
[TBL] [Abstract] [Full Text] [Related]
16. Transradial versus transfemoral approach for TACE: a retrospective study.
You K; Guo T; Sun D; Song H; Liu Z
BMC Gastroenterol; 2023 Jan; 23(1):11. PubMed ID: 36631744
[TBL] [Abstract] [Full Text] [Related]
17. Decreased autophagosome biogenesis, reduced NRF2, and enhanced ferroptotic cell death are underlying molecular mechanisms of non-alcoholic fatty liver disease.
Liu P; Anandhan A; Chen J; Shakya A; Dodson M; Ooi A; Chapman E; White E; Garcia JG; Zhang DD
Redox Biol; 2023 Feb; 59():102570. PubMed ID: 36495698
[TBL] [Abstract] [Full Text] [Related]
18. A subset of VEGFR-TKIs activates AMPK in LKB1-mutant lung cancer.
Yang L; Zhang Q; Xiong Y; Dang Z; Xiao H; Chen Q; Dai X; Zhang L; Zhu J; Wang D; Li M
Cancer Sci; 2023 Apr; 114(4):1651-1662. PubMed ID: 36459496
[TBL] [Abstract] [Full Text] [Related]
19. AKR1C3-dependent lipid droplet formation confers hepatocellular carcinoma cell adaptability to targeted therapy.
Wu C; Dai C; Li X; Sun M; Chu H; Xuan Q; Yin Y; Fang C; Yang F; Jiang Z; Lv Q; He K; Qu Y; Zhao B; Cai K; Zhang S; Sun R; Xu G; Zhang L; Sun S; Liu Y
Theranostics; 2022; 12(18):7681-7698. PubMed ID: 36451864
[No Abstract] [Full Text] [Related]
20. Discovery and optimization of 2-(trifluoromethyl)benzimidazole derivatives as novel ferroptosis inducers in vitro and in vivo.
Fang Y; Tan Q; Zhou H; Xu J; Gu Q
Eur J Med Chem; 2023 Jan; 245(Pt 1):114905. PubMed ID: 36410168
[TBL] [Abstract] [Full Text] [Related]
[Next]
